These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34306318)

  • 1. Head and Neck Cancer Cell Death due to Mitochondrial Damage Induced by Reactive Oxygen Species from Nonthermal Plasma-Activated Media: Based on Transcriptomic Analysis.
    Oh C; Won HR; Kang WS; Kim DW; Jung SN; Im MA; Liu L; Jin YL; Piao Y; Kim HJ; Kang YE; Lee MJ; Heo JY; Jun S; Sim NS; Lee JH; Song K; Kim YI; Chang JW; Koo BS
    Oxid Med Cell Longev; 2021; 2021():9951712. PubMed ID: 34306318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species.
    Kang SU; Cho JH; Chang JW; Shin YS; Kim KI; Park JK; Yang SS; Lee JS; Moon E; Lee K; Kim CH
    Cell Death Dis; 2014 Feb; 5(2):e1056. PubMed ID: 24525732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
    Kim EH; Jang H; Roh JL
    Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
    Kim EH; Jang H; Shin D; Baek SH; Roh JL
    Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
    Kim EH; Shin D; Lee J; Jung AR; Roh JL
    Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.
    Kim EH; Baek S; Shin D; Lee J; Roh JL
    Oxid Med Cell Longev; 2017; 2017():5498908. PubMed ID: 29456786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition.
    Roh JL; Kim EH; Jang H; Shin D
    Free Radic Biol Med; 2017 Mar; 104():1-9. PubMed ID: 28057599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGR1/GADD45α Activation by ROS of Non-Thermal Plasma Mediates Cell Death in Thyroid Carcinoma.
    Jung SN; Oh C; Chang JW; Liu L; Lim MA; Jin YL; Piao Y; Kim HJ; Won HR; Lee SE; Lee MJ; Heo JY; Jun S; Lee D; Kang WS; Kim DW; Rha KS; Kim YI; Kang YE; Koo BS
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway.
    Wang SF; Chen MS; Chou YC; Ueng YF; Yin PH; Yeh TS; Lee HC
    Oncotarget; 2016 Nov; 7(45):74132-74151. PubMed ID: 27708226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
    Lee J; You JH; Shin D; Roh JL
    Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
    [No Abstract]   [Full Text] [Related]  

  • 15. An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation.
    Lee BS; Kang SU; Hwang HS; Kim YS; Sung ES; Shin YS; Lim YC; Kim CH
    Cancer Lett; 2012 Sep; 322(1):45-57. PubMed ID: 22353688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer.
    Roh JL; Kim EH; Park JY; Kim JW; Kwon M; Lee BH
    Oncotarget; 2014 Oct; 5(19):9227-38. PubMed ID: 25193861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.
    Roh JL; Kim EH; Park JY; Kim JW
    Mol Cancer Ther; 2015 Aug; 14(8):1907-15. PubMed ID: 26063766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.
    Kleih M; Böpple K; Dong M; Gaißler A; Heine S; Olayioye MA; Aulitzky WE; Essmann F
    Cell Death Dis; 2019 Nov; 10(11):851. PubMed ID: 31699970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4,6-Trinitrotoluene Induces Apoptosis via ROS-Regulated Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in HepG2 and Hep3B Cells.
    Liao HY; Kao CM; Yao CL; Chiu PW; Yao CC; Chen SC
    Sci Rep; 2017 Aug; 7(1):8148. PubMed ID: 28811603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells.
    Kim MC; Hwang SH; Yang Y; Kim NY; Kim Y
    Neoplasia; 2021 Jul; 23(7):653-662. PubMed ID: 34134082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.